TCR2 Company
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Technology:
Cell-based gene therapy
Industry:
PharmTech, Public
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2015-01-01
Employees Number:
101-250
Funding Status:
M&A
Investors Number:
14
Total Funding:
173300000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2018-03-21
Last Funding Type:
Series B
Register and Claim Ownership